Several recent survey results, including from the Pew Research Center, show an increase in support and interest in cannabis in the US.
On March 26, 2024, Pew Research Center released a report on survey results regarding opinions on cannabis in the US (1). The study was conducted from January 16–21, 2024 and collected data from 5,140 adults representative of the US population in several categories (1). One of the major findings was that only 11% of respondents stated that cannabis should not be legal at all (1). The majority (57% of respondents) stated that cannabis should be legal for both recreational and medical uses, and 32% stated that it should be legal for medical uses only (1). “Opinions about marijuana legalization have changed little over the past five years,” the report noted (1).
The study also reported data on the perceived impacts of cannabis legalization, with 52% of respondents stating that legalizing cannabis is good for local economies, 29% stating that it produces no effect, and 17% stating that it is bad for local economies (1). “More adults also say legalizing marijuana for recreational use makes the criminal justice system more fair (42%) than less fair (18%); 38% say it has no impact,” the study added (1).
The study also broke down the data based on partisan differences, ages, and race and ethnicity, observing several conclusions including (1):
In a separate study, Pew Research Center also recently collected data on the number of Americans living in states with legal cannabis and on the number of dispensaries in each state (2). In February 2024, it reported that 79% of all Americans live in a state with at least one cannabis dispensary, with California having the most dispensaries by far—over 3600 out of the 15,000 total in the US (2). “These changes in state law come as a broad majority of Americans say marijuana should be legal in some way,” the study noted, citing its 2022 survey (2). Additionally, most Americans (54%) live in a state with legal recreational cannabis, and 74% live in a state with either medical or recreational cannabis (2).
According to a report earlier this year from BioWellnessX, a producer of hemp-derived tetrahydrocannabinol (THC) products, search trends indicated that Mississippi residents have shown the most interest in medical cannabis in 2024 (3). After analyzing state populations and monthly search data from Google on keywords related to medical cannabis, Mississippi showed 294.59 searches per 100,000 residents, followed by Arkansas and Alaska with 233 and 222 searches per 100,000 residents, respectively (3). There were nearly 500,000 monthly searches nationwide (3). “A total of 488,230 monthly searches nationwide signifies that medical marijuana has become a mainstream topic across the US,” the study stated (3).
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.